share_log

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Alpern Robert J

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Alpern Robert J

艾伯维公司 | 4：持股变动声明-董事 Alpern Robert J
美股SEC公告 ·  05/07 18:36
Moomoo AI 已提取核心信息
On May 3, 2024, Robert J Alpern, associated with AbbVie Inc. [ABBV], was granted 1,322 shares of common stock at no cost. Following this transaction, Alpern's direct holdings in the company increased to a total of 34,443 shares. The grant, which is part of a standard company award or acquisition process, was completed on the same day. The shares acquired have a par value of $0.01 each, and the transaction was conducted in USD. This event could indicate the company's ongoing investment in its leadership team, potentially affecting investor sentiment.
On May 3, 2024, Robert J Alpern, associated with AbbVie Inc. [ABBV], was granted 1,322 shares of common stock at no cost. Following this transaction, Alpern's direct holdings in the company increased to a total of 34,443 shares. The grant, which is part of a standard company award or acquisition process, was completed on the same day. The shares acquired have a par value of $0.01 each, and the transaction was conducted in USD. This event could indicate the company's ongoing investment in its leadership team, potentially affecting investor sentiment.
2024年5月3日，与艾伯维公司 [ABBV] 关联的罗伯特·阿尔珀恩免费获得了1,322股普通股。在这笔交易之后，Alpern在该公司的直接持股量增加到总计34,443股。该补助金是标准公司奖励或收购过程的一部分，已于当天完成。收购的股票每股面值为0.01美元，交易以美元进行。该事件可能表明该公司正在对其领导团队进行投资，这可能会影响投资者的情绪。
2024年5月3日，与艾伯维公司 [ABBV] 关联的罗伯特·阿尔珀恩免费获得了1,322股普通股。在这笔交易之后，Alpern在该公司的直接持股量增加到总计34,443股。该补助金是标准公司奖励或收购过程的一部分，已于当天完成。收购的股票每股面值为0.01美元，交易以美元进行。该事件可能表明该公司正在对其领导团队进行投资，这可能会影响投资者的情绪。
有用
没用

该公告为独立文件：

独立文件1

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息